The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice

Amos J. de Jong, Mira G.P. Zuidgeest, Yared Santa-Ana-Tellez, Christine E. Hallgreen, Thomas T. van Sloten, Anthonius de Boer, Helga Gardarsdottir*,

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Decentralized clinical trial (DCT) approaches – in which trial activities are conducted at participants’ homes – have the potential to improve representativeness. We present a study that compared the demographics and cardiovascular risk factors of participants from a DCT (ASCEND) and a conventional trial with a similar trial objective (POPADAD) to those of patients in daily practice. We adjudicate that there are relevant differences when comparing the participants of the conventional trial and the DCT, with the latter providing better representativeness in terms of age, insulin use, smoking status, and body mass index, whereas conventional trial participants were more representative in terms of biological sex. Differences in these characteristics were not explained by the eligibility criteria, but are considered attributable to the operational trial approach.

Original languageEnglish
Article number104304
Number of pages11
JournalDrug Discovery Today
Volume30
Issue number2
DOIs
Publication statusPublished - Feb 2025

Keywords

  • clinical trial operations
  • decentralized clinical trials
  • generalizability
  • participant representativeness

Fingerprint

Dive into the research topics of 'The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice'. Together they form a unique fingerprint.

Cite this